Back to Search Start Over

Manipulating the 3D organization of the largest synthetic yeast chromosome.

Authors :
Zhang W
Lazar-Stefanita L
Yamashita H
Shen MJ
Mitchell LA
Kurasawa H
Lobzaev E
Fanfani V
Haase MAB
Sun X
Jiang Q
Goldberg GW
Ichikawa DM
Lauer SL
McCulloch LH
Easo N
Lin SJ
Camellato BR
Zhu Y
Cai J
Xu Z
Zhao Y
Sacasa M
Noyes MB
Bader JS
Deutsch S
Stracquadanio G
Aizawa Y
Dai J
Boeke JD
Source :
Molecular cell [Mol Cell] 2023 Dec 07; Vol. 83 (23), pp. 4424-4437.e5. Date of Electronic Publication: 2023 Nov 08.
Publication Year :
2023

Abstract

Whether synthetic genomes can power life has attracted broad interest in the synthetic biology field. Here, we report de novo synthesis of the largest eukaryotic chromosome thus far, synIV, a 1,454,621-bp yeast chromosome resulting from extensive genome streamlining and modification. We developed megachunk assembly combined with a hierarchical integration strategy, which significantly increased the accuracy and flexibility of synthetic chromosome construction. Besides the drastic sequence changes, we further manipulated the 3D structure of synIV to explore spatial gene regulation. Surprisingly, we found few gene expression changes, suggesting that positioning inside the yeast nucleoplasm plays a minor role in gene regulation. Lastly, we tethered synIV to the inner nuclear membrane via its hundreds of loxPsym sites and observed transcriptional repression of the entire chromosome, demonstrating chromosome-wide transcription manipulation without changing the DNA sequences. Our manipulation of the spatial structure of synIV sheds light on higher-order architectural design of the synthetic genomes.<br />Competing Interests: Declaration of interests J.D.B. is a founder and director of CDI Labs, Inc.; a founder of and consultant to Neochromosome, Inc; and a founder, Scientific Advisory Board (SAB) member of, and consultant to ReOpen Diagnostics, LLC. J.D.B. also serves or served on the SABs of the following: Logomix, Inc.; Sangamo, Inc.; Modern Meadow, Inc.; Rome Therapeutics, Inc.; Sample6, Inc.; Tessera Therapeutics, Inc.; and the Wyss Institute. Y.A. is a Founder and CSO of Logomix, Inc.<br /> (Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.)

Details

Language :
English
ISSN :
1097-4164
Volume :
83
Issue :
23
Database :
MEDLINE
Journal :
Molecular cell
Publication Type :
Academic Journal
Accession number :
37944526
Full Text :
https://doi.org/10.1016/j.molcel.2023.10.015